Medtronic
Quarterly Financials
| Values in thousands | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 |
|---|---|---|---|---|
Revenue | $8,403,000 | $7,915,000 | $8,589,000 | $8,089,000 |
Gross Profit | 5,457,000 | 4,712,000 | 5,197,000 | 5,307,000 |
EBITDA | 2,443,000 | 2,048,000 | 2,498,000 | 2,200,000 |
EBIT | 1,768,000 | 1,386,000 | 1,844,000 | 1,551,000 |
Net Income | 1,270,000 | 1,042,000 | 654,000 | 1,322,000 |
Net Change In Cash | 8,403,000 | 7,915,000 | 8,589,000 | 8,089,000 |
Free Cash Flow | 554,000 | 466,000 | 2,351,000 | 2,128,000 |
Cash | 1,394,000 | 1,311,000 | 1,284,000 | 1,623,000 |
Basic Shares | 1,286,900 | 1,296,500 | 1,325,400 | 1,331,700 |
Annual Financials
| Values in thousands | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|
Revenue | $32,364,000 | $31,227,000 | $31,686,000 | $30,117,000 |
Gross Profit | 21,148,000 | 20,508,000 | 21,541,000 | 19,634,000 |
EBITDA | 8,203,000 | 8,475,000 | 9,554,000 | 8,192,000 |
EBIT | 5,556,000 | 5,778,000 | 6,847,000 | 5,490,000 |
Net Income | 3,676,000 | 3,758,000 | 5,039,000 | 3,606,000 |
Net Change In Cash | 32,364,000 | 31,227,000 | 31,686,000 | 30,117,000 |
Cost of Revenue | -2,414,000 | 351,000 | -762,000 | |
Free Cash Flow | 5,200,000 | 4,580,000 | 5,978,000 | 4,885,000 |
Cash | 1,284,000 | 1,543,000 | 3,714,000 | 3,593,000 |
Basic Shares | 1,330,200 | 1,332,800 | 1,351,400 | 1,354,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-10-31 | $1.26 |
2024-07-31 | $1.23 |
2024-04-30 | $1.46 |
2024-01-31 | $1.30 |
